Greg Wiseman
Impact in
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 3
- Oncology 3
- CAR-T cell therapy research 1
- Co-authors
- Thomas Elmer Witzig (2 shared papers)Christos E. Emmanouilides (2 shared papers)Mohamed Darif (2 shared papers)Arturo Molina (2 shared papers)Leo I. Gordon (2 shared papers)Christine A. White (1 shared paper)Russell J. Schilder (1 shared paper)Adam Robinson (1 shared paper)
- Journals
- BMJ Open (1 paper)The Medical Journal of Australia (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Greg Wiseman
12 papers receiving 796 citations
Peers
Comparison fields: 5 of 68
- Oncology 418
- Pathology and Forensic Medicine 209
- Radiology, Nuclear Medicine and Imaging 208
- Cancer Research 124
- Genetics 59
Countries citing papers authored by Greg Wiseman
This map shows the geographic impact of Greg Wiseman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Greg Wiseman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Greg Wiseman more than expected).
Fields of papers citing papers by Greg Wiseman
This network shows the impact of papers produced by Greg Wiseman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Greg Wiseman. The network helps show where Greg Wiseman may publish in the future.
Co-authors
The 25 scholars most cited alongside Greg Wiseman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. | 2003 | 395 |
| 2 | 2004 | 153 | |
| 3 | 2004 | 98 | |
| 4 | 2013 | 67 | |
| 5 | 2013 | 39 | |
| 6 | Radiation exposure is very low to patient family members following Zevalin yttrium-90 anti-CD20 monoclonal antibody therapy for lymphoma | 2001 | 24 |
| 7 | 2016 | 13 | |
| 8 | 2017 | 12 | |
| 9 | 2018 | 10 | |
| 10 | Management of Pediatric Thoracic Empyema in the North Queensland Region of Australia and Impact of a Local Evidence-based Treatment Guideline | 2022 | 3 |
| 11 | 2022 | 3 | |
| 12 | 2014 | 1 |
About Greg Wiseman
Greg Wiseman is a scholar working on Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Critical Care and Intensive Care Medicine and Molecular Medicine, having authored 12 papers that have together received 818 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (3 papers), Pleural and Pulmonary Diseases (2 papers), Inflammatory Bowel Disease (2 papers), CAR-T cell therapy research (1 paper), Respiratory viral infections research (1 paper), Heme Oxygenase-1 and Carbon Monoxide (1 paper), Legionella and Acanthamoeba research (1 paper) and Burkholderia infections and melioidosis (1 paper). The work is most often cited by research in Oncology (418 citations), Pathology and Forensic Medicine (209 citations), Radiology, Nuclear Medicine and Imaging (208 citations), Cancer Research (124 citations) and Genetics (59 citations). Greg Wiseman has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Thomas Elmer Witzig, Christos E. Emmanouilides, Mohamed Darif, Arturo Molina, Leo I. Gordon, Christine A. White, Russell J. Schilder, Adam Robinson, Michael Jones and Matthew C. Hankins. Their work appears in journals such as BMJ Open, The Medical Journal of Australia, European Journal of Nuclear Medicine and Molecular Imaging, Alimentary Pharmacology & Therapeutics and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.